All News about Abcellera Biologics IncVia Business Wire
The Latest Analyst Ratings for AbCellera Biologics
January 06, 2023
Via Benzinga
AbCellera and AbbVie Partner to Advance New Antibody Therapies
December 15, 2022
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via Benzinga
AbCellera Reports Q3 2022 Business Results
November 08, 2022
Via Business Wire
AbCellera to Present at Upcoming Investor Conferences in November
November 04, 2022
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|